Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2026 16:05 ET | Source: Castle Biosciences, Inc.

Castle Biosciences Reports Fourth Quarter and Full–Year 2025 Results

Castle today announced its financial results for the fourth quarter and year ended Dec. 31, 2025.
February 26, 2026 08:30 ET | Source: Quoin Pharmaceuticals, Inc.

NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome

NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome
February 19, 2026 17:46 ET | Source: Castle Biosciences, Inc.

Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis

Castle announced the publication of a validation study in the Journal of the American Academy of Dermatology for its AdvanceAD-Tx test.
February 18, 2026 10:02 ET | Source: South Beach Symposium

South Beach Symposium and Masters of Pediatric Dermatology Mark Another Year of Dermatology Education in Miami Beach

Miami, FL, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The 2026 South Beach Symposium (SBS) and Masters of Pediatric Dermatology (MOPD) wrapped up their annual meetings in Miami Beach from Thursday, Feb. 5...
February 12, 2026 21:21 ET | Source: InnoCare Pharma

InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China

The current indications of soficitinib under development are strategically positioned within the vast dermatology market.
February 11, 2026 08:00 ET | Source: LASEROPTEK AMERICA CORP.

Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences

Laseroptek America Corp. today announced that it has filed counterclaims and third-party claims against Strata Skin Science
February 10, 2026 07:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy

36 abstracts to be presented across Regeneron-invented therapies, including first-time Phase 3 presentations for two distinct investigational allergen-blocking antibodies for cat and birch allergies ...
February 06, 2026 18:22 ET | Source: Astanza Laser

Correction: Astanza Laser Appointed Sole Distributor for Dermalosophy USA Professional Skincare

Dallas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Astanza Laser, an award-winning and trusted provider of aesthetic laser technology, service, marketing support, and training, has been appointed the exclusive...
February 05, 2026 17:02 ET | Source: Astanza Laser

Astanza Laser Appointed Sole Distributor for Dermalosophy USA Professional Skincare

Dallas, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Astanza Laser, an award-winning and trusted provider of aesthetic laser technology, service, marketing support, and training, has been appointed the exclusive...
February 02, 2026 10:00 ET | Source: Dermatology Times

MJH Life Sciences® announces new era in dermatology NP/PA education and engagement

MJH Life Sciences launches Dermatology Times NP/PA Connect and CME meetings to advance dermatology NP/PA education.